APA

Bocket L., Cheret A., Deuffic-Burban S., Choisy P., Gerard Y., de la Tribonnière X., Viget N., Ajana F., Goffard A., Barin F., Mouton Y. & Yazdanpanah Y. (20050729). Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness. : Antiviral therapy.

Chicago

Bocket Laurence, Cheret Antoine, Deuffic-Burban Sylvie, Choisy Philippe, Gerard Yann, de la Tribonnière Xavier, Viget Nathalie, Ajana Faïzo, Goffard Anne, Barin Francis, Mouton Yves and Yazdanpanah Yazdan. 20050729. Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness. : Antiviral therapy.

Harvard

Bocket L., Cheret A., Deuffic-Burban S., Choisy P., Gerard Y., de la Tribonnière X., Viget N., Ajana F., Goffard A., Barin F., Mouton Y. and Yazdanpanah Y. (20050729). Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness. : Antiviral therapy.

MLA

Bocket Laurence, Cheret Antoine, Deuffic-Burban Sylvie, Choisy Philippe, Gerard Yann, de la Tribonnière Xavier, Viget Nathalie, Ajana Faïzo, Goffard Anne, Barin Francis, Mouton Yves and Yazdanpanah Yazdan. Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness. : Antiviral therapy. 20050729.